A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC) - Publikation - Autoren - KSSG Forschungsdatenbank

Publikation

A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)

Wissenschaftlicher Artikel/Review - 13.03.2006

Kollmannsberger C, Schittenhelm Marcus, Honecker F, Tillner J, Weber D, Oechsle K, Kanz L, Bokemeyer C

Kollmannsberger, C

Schittenhelm, Marcus

Leitender Arzt
Ärztliche Leitung Ambulatorium Spital Linth
Medizinische Onkologie und Hämatologie · Dept. I

Honecker, F

Tillner, J

Weber, D

Oechsle, K

Kanz, L

Bokemeyer, C